| Name | KRAS G12C inhibitor 29 |
|---|
| Description | KRAS G12C inhibitor 29 is a KRAS G12C inhibitor extracted from patent WO2021252339A1, compound 3. KRAS G12C inhibitor 29 can be used for the research of cancer[1]. |
|---|---|
| Related Catalog | |
| Target |
KRAS G12C[1] |
| References |
[1]. Fan J, et, al. Substituted purine-2,6-dione compounds as kras inhibitors. WO2021252339A1. |
| Molecular Formula | C23H21ClFN5O2 |
|---|---|
| Molecular Weight | 453.90 |